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We synthesize a large gene expression data set using dbEST and UniGene. We use guilt-by-association (GBA) to
analyze this data set and identify coexpressed genes. One module, or group of genes, was found to be
coexpressed mainly in tissue extracted from breast and ovarian cancers, but also found in tissue from lung
cancers, brain cancers, and bone marrow. This module contains at least six members that are believed to be
involved in either transcritional regulation (PDEF, H2AFO, NUCKS) or the ubiquitin proteasome pathway
(PSMD7, SQSTM1, FLJ10111). We confirm these observations of coexpression by real-time RT–PCR analysis of
mRNA extracted from four model breast epithelial cell lines.
Molecular studies of cellular functions have led to broad
knowledge of cellular processes. Most cellular processes are
the result of molecules interacting, rather than due to the
activity of individual molecules. The study of functional
groups of genes has been termed modular cell biology
(Hartwell et al. 1999). We are interested in identifying func-
tional modules.
Technical constraints make the study of individual genes
much easier than identifying interacting molecules. One ap-
proach to identify modules is to examine genome scale ex-
pression data.
Genes coexpressed in many different tissues, under both
normal and diseased conditions, and at different times during
development, are candidates for forming functional modules.
There are different types of experimental gene expression
data sets available for use to identify modules. DNA microar-
ray experiments measure mRNA expression levels on a known
set of genes by way of hybridization. A fluorescent tag is put
on an unknown single-stranded DNA molecule. A set of
single-stranded DNAs of known sequence is immobilized
onto a surface at known locations. The unknown fluores-
cently tagged sample is allowed to hybridize to its compli-
mentary immobilized strand. The surface is scanned to create
a fluorescent image. The intensity of the fluorescence is a
measure of the concentration of DNA in the sample.
Substantial DNA microarray data sets exist, but are not
easy to compare between different laboratories. These mea-
surements are made relative to a control and the numbers are
reported as a fold difference relative to the control. The spe-
cific choice for a control varies widely between different labo-
ratories. Most troubling is the lack of any reported error in
these measurements. Hence, there is little systematic informa-
tion available on how certain the experimenter is of the re-
ported value.
Similar expression data measurements can be made by
DNA sequencing. Message RNA molecules isolated from a tis-
sue are reverse transcribed into cDNA and cloned into Esch-
erichia coli vectors to generate a library. Random clones are
sampled from the library and a few hundred base pairs are
sequenced from each. These are known as expressed sequence
tags (ESTs). The sequence read from each clone is generally
sufficient to identify the gene when cross referenced to a con-
sensus sequence data set.
The UniGene data set (Schuler et al. 1996) groups the
large number of publicly available DNA sequence fragments
on the basis of sequence overlaps into unique genes. In addi-
tion to complete sequences of some well-known genes, there
are thousands of uncharacterized EST fragments that are
found as a result of the clustering process. These uncharacter-
ized EST fragments are thought to represent previously un-
characterized genes.
Recently, concerted efforts have been formed to con-
struct a diverse set of cDNA libraries derived from various
tissues in normal and diseased states. These libraries are
heavily influenced by the National Cancer Institute’s Cancer
Genome Anatomy Project (CGAP), whose stated goals are to
characterize normal, precancerous, andmalignant cells. These
libraries, when combined with the UniGene collection, pro-
vide a set of gene expression data that can be analyzed to
identify groups of coexpressed genes.
In general, EST sequencing is more accurate but substan-
tially more expensive than DNA microarrays. DNA microar-
rays suffer from cross-hybridization, uncertain linearity, and
numerous other technical problems. However, they are al-
most always more sensitive and cheaper to use. (The sensitiv-
ity of EST sequencing is limited by the depth of sampling into
the library. The costs increase linearly with the depth of se-
quencing.) However, EST sequencing provides data that is eas-
ily comparable across different experiments. EST sequencing
provides absolute numbers that represent a sampling of the
mRNAs present in a tissue sample.
The specific purpose of this analysis is to identify func-
tional modules from gene expression data by identifying
groups of genes that are coexpressed. Our hypothesis is that
coexpression has functional significance. Our approach of
analyzing gene expression across all tissues (rather than just
comparing pairs of diseased and normal tissue), offers two
advantages. First, because only genes similarly expressed
across all tissues will be grouped together, the identification
of both tissue-specific and tissue-generic modules is possible.
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Second, modules of genes that have a specific and normal
function in, for instance, the development of the fetal brain,
but also play a pathologic role in, for example, some forms of
cancer due to mutations that lead to misregulation may be
identified.
Although dbEST (Benson et al. 2002) contains sequence
data from many different laboratories, the vast majority of
sequence analyzed in this study is derived either from the
Washington University/Merck EST project (Hillier et al. 1996)
or the National Cancer Institute’s Cancer Genome Anatomy
Project (CGAP).
The simple listing of ESTs, as is provided in dbEST, is
insufficient for large-scale gene expression analysis. A cluster-
ing (or assembly) of the ESTs into unique genes is also needed.
At least two databases have been established to do this. The
first, UniGene (Wheeler et al. 2002), is regularly updated and
available freely online. The second, TIGR Human Gene Index
(Quakenbush et al. 2000), is available with a restrictive li-
cense. The data presented in this study is based on the analy-
sis of gene expression data compiled in the UniGene database.
Analysis algorithms for gene expression data fall into two
classes. The first identifies differentially expressed genes be-
tween two experiments (cells under different conditions, tis-
sues, or groups of tissues). This is most simply done with a
Fisher’s Exact test, but can also use more rigorous statistical
methods (Audic and Claverie 1997; Stekel et al. 2000). The
second class of algorithms seeks to identify groups of genes
with similar patterns of expression across many (hundreds)
different experiments. We need an algorithm from this sec-
ond class.
Many different approaches have been used to classify
and organize gene expression data. Most algorithms are varia-
tions on Eisen’s approach (Eisen et al. 1998) of organizing the
data on the basis of similarity of gene expression. A different
approach, guilt-by-association (GBA) was described byWalker
et. al (1999) and used to identify novel genes with expression
patterns similar to those of known disease-related genes in a
private (Incyte’s LifeSeq) gene expression data set generated
from ESTs. In this work, we used the GBA algorithm to iden-
tify genes with similar expression patterns.
In this study, we first constructed a large set of human
expression data from dbEST and UniGene. The data set was
found to be reliable on the basis of its identification of ubiq-
uitously expressed genes and known coexpressed genes.
Then, we analyzed this data set to identify modules of coex-
pressed genes. The analysis identified potential functional
modules. One was identified in the literature as a module
expressed during pregnancy (Thompson et al. 1990), further
confirming the reliability of the data set. We also identi-
fied a set of coexpressed genes that may form a novel func-
tional module. The members of this functional module are
not well studied in the literature. We examined gene expres-
sion in several cell lines to confirm that these genes are coex-
pressed.
RESULTS
After constructing the gene expression data set, we first ex-
amined ubiquitously expressed genes as a check on the valid-
ity of the data set. Genes that showed the widest expression
(found in the greatest number of libraries) are shown in Table
1. No genes appear in more than one-third of the libraries.
Table 1. The Ten Most Ubiquitously Expressed Genes
in the Dataset
Total Gene Description
422 EEF1A1 eukaryotic translation elongation factor 1
alpha 1
422 ACTB actin, beta
371 ACTG1 actin, gamma 1
356 GAPD glyceraldehyde-3-phosphate dehydrogenase
354 RPLP0 ribosomal protein, large, P0
353 EEF1G eukaryotic translation elongation factor 1
gamma
342 TPT1 tumor protein, translationally-controlled 1
334 RPL13A ribosomal protein L13a
330 HDAC3 histone deacetylase 3
326 RPS4X ribosomal protein S4, X-linked
There were 1573 libraries examined and the above ten appeared
in the greatest number of libraries. Total indicates the number of
libraries (of 1573) in which that particular gene was found to be
expressed.
Table 2. A Module of Genes That Is Expressed During Pregnancy
Coinc Total Gene Description
9 16 PSG4 pregnancy specific -1-glycoprotein 4
10 65 CHS1 chorionic somatomammotropin hormone 1 (placental lactogen)
11 23 PSG9 pregnancy specific -1-glycoprotein 9
7 8 PSG3 pregnancy specific -1-glycoprotein 3
9 12 PSG6 pregnancy specific -1-glycoprotein 6
7 13 PSG2 pregnancy specific -1-glycoprotein 2
7 22 PAPPA pregnancy-associated plasma protein A
7 15 CSH2 chorionic somatomammotropin hormone 2
10 17 CYP19 cytochrome P450, subfamily XIX (aromatization of androgens)
10 30 DAM12 a disintegrin and metalloproteinase domain 12 (meltrin alpha)
8 15 PSG5 pregnancy specific -1-glycoprotein 5
11 46 TFPI2 tissue factor pathway inhibitor 2
5 5 PSG7 pregnancy specific -1-glycoprotein 7
11 356 GAPD glyceraldehyde-3-phosphate dehydrogenase
The genes are listed relative to PSG1 (pregnancy specific -1-glycoprotein), which is found in 13 different libraries.
The table lists (coinc) the number of libraries in which both PSG1 and the listed gene are both found and (total) the
number of libraries in which the listed gene is found, but PSG1 is not found. For example, PSG4 is found in a total
of 16 libraries, PSG1 is present in a total of 13 libraries. In 9 of the 13 libraries that PSG1 is found in, PSG9 is also found.
GAPD is shown for reference.
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The results of our analysis for coexpressed genes revealed
both known relationships and unknown relationships. We
highlight one of the known relationships as anecdotal evi-
dence for the effectiveness of this approach. Table 2 shows the
10 genes with expression patterns most similar to pregnancy
specific -1-glycoprotein. The pregnancy-specific glycoproteins
are a group of proteins that are found in large amounts in
placenta (Thompson et al. 1990). They are all located on chro-
mosome 19 and share common transcriptional regulatory el-
ements (Thompson et al. 1990).
A postulated functional module is shown in Table 3.
These five genes are all shown with their coexpression relative
to PDEF, a recently described transcription factor (Oettgen et
al. 2000). To better understand the role of this module, we
examined the tissues in which it was expressed. We found the
module to be expressed in some breast (Table 4) and ovary
(Table 5) tissues. The module is also expressed in several other
brain, lung cancer, and bone marrow tissues (Table 6).
Many other significant relationships were found be-
tween pairs of genes. Significance of a relationship was de-
fined, following Walker et al. (1999), by a P-value, indicating
the probability that the coexpression was due to chance. Over
29,000 gene pairs showed a P-value of <106. The distribution
of these P-values is shown in Figure 1 along with the approxi-
mate range of P-values for the functional modules described
in this work. There is not necessarily a clear relationship of
what constitutes a module. The structure of the data is more
like a complex web then a group of distinct modules and our
definition of which genes belong to the PDEF module is prob-
ably not complete.
To confirm the observation of coexpression, we per-
formed quantitative reverse transcriptase real-time PCR on
four different cell lines derived from mammary epithelial tis-
sue. We measured the quantity of mRNA from PDEF and the
five other genes shown in Table 3, along with a control,
GAPD. Results are shown in Figure 2.
DISCUSSION
Examination of the most ubiquitously expressed genes (Table
1) provides interesting insight into the typical population of
cellular mRNAs. As expected, most of these mRNAs code for
well-known ubiquitously expressed proteins (components of
the ribosome, structural proteins, and enzymes). However,
one protein labeled tumor protein, translationally controlled
1 or TPT1, is prominent due to its obscurity in the literature.
Although its name implies association with cancer, it is better
described as a histamine releasing factor (HRF) and has been
studied as playing a role in the allergic response of mast cells
that results in the exocytosis of histamine. However, its ubiq-
uitous nature perhaps indicates it plays a much larger role in
cellular signaling. In fact, the recent determination of the
structure of this protein (Thaw et al. 2001) revealed significant
similarity to Mss4, a small GTPase accessory protein involved
in amplification of extracellular signals. Our finding that
TPT1 is ubiquitously expressed is supported by other works.
Table 3. A Module (the PDEF Module) of Genes That Is Expressed in Breast and Ovary Cancers
Coinc Total Gene Description
9 46 H2AFO H2A histone family, member O
22 105 PSMD7 proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 (Mov34 homolog)
16 104 NUCKS similar to rat nuclear ubiquitous casein kinase 2
14 51 FLJ10111 hypothetical protein FLJ10111
21 203 SQSTM1 sequestosome 1
10 356 GAPD glyceraldehyde-3-phosphate dehydrogenase
The genes are listed relative to PDEF (prostate derived Ets factor, a transcription factor), which is found in 27 different
libraries. The table lists (Coinc) the number of libraries in which both PDEF and the listed gene are both found and
(Total) the number of libraries in which the listed gene is found, but PDEF is not found. GAPD is shown for reference.
Table 4. The Expression of the PDEF Module in Libraries
Derived from Breast Tissues
ID Description
517 invasive ductal breast tumors (pooled bulk)
557 ductal tumor (bulk)
590 infiltrating ductal carcinoma (microdissected)
634 normal (bulk)
730 • carcinoma: in situ (microdissected)
759 • carcinoma: invasive (microdissected)
766 • adenocarcinoma (microdissected)
768 • carcinoma: lobular (microdissected)
770 • adenocarcinoma (microdissected)
931 high grade neoplasia (bulk)
726 • normal epithelium (microdissected)
583 normal ductal tissue (microdissected)
The bullets indicate in which libraries the PDEF module is present.
ID is the UniGene library identification number.
Table 5. The Expression of the PDEF Module in Libraries
Derived from Ovary Tissues
ID Description
186 tumor/normal (bulk)
389 normal (bulk)
390 71 yrs old normal (bulk)
514 invasive tumor serous, papillary, adenocarcinoma
(micro-bulk)
564 serous papillary adenocarcinoma (bulk)
652 serous adenocarcinoma (bulk)
675 • serous papillary carcinoma (microdissected)
706 • borderline neoplasia (microdissected)
708 • borderline preneoplasia (microdissected)
709 • invasive carcinoma (microdissected)
710 • invasive carcinoma (microdissected)
731 • borderline preneoplasia (microdissected)
765 serous papillary carcinoma (microdissected)
717 serous papillary, clear cell, spindle cell, carcinoma (bulk)
The labels are identical to those in Table 2.
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One study used SAGE to exhaustively enumerate the popula-
tions of mRNAs within colorectal cancer cell lines (Velculescu
et al. 1999) and found TPT1 to be among the most abundant
mRNAs in those cell lines. A second study found a yeast ho-
molog to TPT1 to be one of the top 20 most abundant pro-
teins by two-dimensional gel analysis (Norbeck and Blomberg
1997).
The reliability of the data set was further confirmed by
examining genes coexpressed with PSG1. The human preg-
nancy-specific glycoproteins (PSGs) form a group of proteins
that are closely clustered on chromosome 19. This group of
genes, along with a few others (CSH1, CSH2) were found in
libraries derived from placenta and fetal tissues. Interestingly,
one library derived from aorta (UniGene Library ID 182) also
contained many of these genes. All of these genes are known
to be specifically expressed in placental tissues.
We also identified members of a novel functional mod-
ule. Six members of this postulated functional module are
reported as follows: PDEF, SQSTM1, FLJ10111, H2AFO,
PSMD7, and NUCKS.
PDEF was first identified as a prostate epithelium-specific
Ets transcription factor that interacts with the androgen re-
ceptor to activate the promoter of the well-known prostate
cancer marker gene, PSA (Oettgen et al. 2000). Simulta-
neously, it was identified and cloned in both human (Nozawa
et al. 2000) and mouse (Yamada et al. 2000), in which it was
identified as a positive regulator of maspin, a protease inhibi-
tor that is down-regulated in advanced breast cancers (Zou et
al. 1994). Later investigators identified PDEF as a candidate
breast tumor marker (Ghadersohi and Sood 2001) and showed
that PDEF mRNA was highly overexpressed in 14 of 20 pri-
mary human breast tumors examined. They also found that
one patient with metastatic breast cancer had PDEF mRNA
192-fold higher in blood as compared with normal individu-
als (Ghadersohi and Sood 2001). Although PDEF mRNA has
been identified as being highly up-regulated in breast cancer
cell lines (Fig. 1) and breast tumors (Ghadersohi and Sood
2001), only two targets [the PSA promoter (Oettgen et al.
2000) and the maspin promoter (Yamada et al. 2000)] have
been identified that PDEF regulates. Little is known about
PDEF’s function, either in breast cancer or in normal tissue.
The class of Ets transcription factors is characterized by
the ETS domain, which binds monomerically to an 8-bp long
DNA element (Dittmer and Nordheim 1998). Most Ets tran-
scription factors bind to the GGAA core sequence of DNA, but
PDEF prefers a GGAT core (Oettgen et al. 2000).
P62 is a widely expressed cytoplasmic protein that is
known to play a role in cellular signaling by interacting with
the SH2 domain of p56(lck) (Park et al. 1995). P62 was also
identified as a ubiquitin-binding protein through a yeast two-
hybrid screen (Vadlamudi et al. 1996). More recently, p62 has
been found to form cytoplasmic structures called intrahyaline
bodies that serve as a storage place for multiubiquitinated
proteins (Shin 1998). The ability of p62 to bind noncovalently
to ubiquitin and several signaling proteins, suggests that p62
may play a regulatory role connected to the ubiquitin–
proteasome system.
The promoter of the SQSTM1 gene has been character-
ized previously (Vadlamudi and Shin 1998). This information,
along with the DNA-binding studies of Oettgen et. al (2000),
allowed us to identify two potential PDEF-binding sites
within the SQSTM1 promoter and to postulate that PDEF
regulates the SQSTM1 promoter. We have performed transfec-
tion experiments showing that PDEF activates the SQSTM pro-
moter (Thompson et al. 2002) threefold over basal levels.
The hypothetical protein FLJ10111 was first identified
and named by the Nedo Full-length cDNA Sequencing Project
in Japan. Although the message for the gene has been found
Figure 1 The cumulative distribution of pairwise P-values. For ex-
ample, ∼1000 gene pairs showed correlations with a P-value <1030
and ∼100 showed correlations with a P-value <1060. The P-values for
each gene pair in the modules described in this work fall within the
indicated regions. Many other significant coexpressions were ob-
served, but not confirmed.
Figure 2 Real-time PCR data quantifying the levels of mRNA tran-
script for each indicated gene in four different cell lines.
Table 6. The PDEF Module Is Also Expressed in Libraries
Derived from Other Tissues
UniGene ID Description
764 • adult bone marrow normal stem cells 34+/38+
(flow sorted)
767 • adult brain oligodendroma (bulk)
771 • adult lung carcinoma: broncholoalveolar
(microdissected)
774 • adult lung adenocarcinoma: invasive
(microdissected)
812 • adult bone marrow (lymphoid tissue) normal
stem cell (bulk)
819 • adult brain oligodendroglioma (bulk)
857 • fetus brain normal (bulk)
The labels are identical to those in Table 2.
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(Yawata et al. 2001), no gene product has yet been character-
ized. Several lines of evidence point to the gene product being
involved in the ubiquitin–proteasome pathway.
FLJ10111 is located in a tightly packed region of chro-
mosome 14 that contains other proteasome-related genes (Ya-
wata et al., 2001). This 35-kb region contains six different
genes, two of which (PA28 and PA28) code for components
of the proteasome activator (PA28), and transcription of genes
in this region is induced by -interferon – suggesting a mode
of regulation. The PA28 proteasome activator is thought to
bind to the 20 S proteasome and enhance the generation of
major histocompatibility complex (MHC) class I-binding pep-
tides (Ma et al. 1992; Yawata et al 2001). The products of the
other four genes in this 35-kb region are not well character-
ized. The predicted protein encoded by FLJ10111 has two
RING finger domains, which are characteristic of E3 ubiquitin
ligases (Yawata et al. 2001). The RING finger motif is found in
many (>200) proteins in different eukaryotes, but not in any
prokaryote proteins (Freemont 2000).
Histones are nuclear proteins responsible for organizing
genomic DNA into the tightly packed chromosomes within
eukaryotic cells. The histones play a role in eukaryotic tran-
scriptional regulation and post-translational modifications
can change their DNA-binding properties. The transcript for
H2AFO, a member of the H2A family, was found among this
group of genes.
The protein encoded by the PSMD7 gene, S12, is a regu-
latory subunit of the proteasome. This protein is homologous
to the mouse Mov34 protein. Mutations in Mov34 are lethal
in the embryonic stage of development. The protein is evo-
lutionary conserved and homologs can be found in yeast,
Drosophila, along with the mouse.
NUCKS is similar (by sequence analysis) to the rat
nuclear ubiquitous casein kinase 2, which was first isolated
from both HeLa cells and rat brain and subsequently found to
be ubiquitously expressed (Ostvold et al. 2001). The protein
localizes to the nucleus and binds single- and double-stranded
DNA. It is phosphorylated at multiple sites by several kinases,
including protein kinase C and casein kinase 2 (Ostvold et al.
1985, 1992; Walaas et al. 1989).
This approach to identifying functionally related mod-
ules of genes has wide applicability. The libraries that com-
prise the data set we examined were largely populated by
those sequenced under the support of the NCI’s CGAP pro-
gram, which is focused on cancer. Hence, it is not surprising
that we identified a cancer-related module. We expect that
concerted expression profiling of other diseased tissues will
uncover functional modules active in those diseases. This
method, however, requires a discovery-based approach to
studying molecular interactions. We queried the data set to
examine some well-known genes and there is no information
available on these. This may be because these genes have
rarely (rather than abundantly) expressed mRNAs and the
paucity of sequences that were read in each library.
The hypothetical functional module that we identified
in this study has members in two distinct classes, transcrip-
tional control (H2AFO, PDEF, and NUCKS) and ubiquitin–
proteasome pathway (PSMD7, SQSTM1, and FLJ10111). The
obvious hypothesis that this leads to is that members of the
first class control the transcription of the second class and
that this occurs in some diseased tissues. We have shown that
PDEF activates the SQSTM1 promoter and that the product of
SQSTM1, p62, is overexpressed in breast cancer samples rela-
tive to normal breast tissue (Thompson et al. 2002).
In summary, we use a method to identify a hypothetical
functional module of coexpressed genes in publicly available
large-scale gene expression data. We confirmed that these
genes are coexpressed by quantitative measurements of
mRNA in cell lines derived from breast tissue. Published in-
formation on the function of the products of these genes
leads to a hypothesis about how these are functionally re-
lated. This work focuses on a small subset of the available
data. The approach has wide applicability and could lead to
the identification of many more functional modules.
METHODS
Computation
We scanned the Homo Sapiens UniGene data set ( build #146,
available at ftp://ftp.ncbi.nlm.nih.gov/repository/UniGene/)
and compiled a list of libraries in which each UniGene ap-
pears. Some appear multiple times in a single library. We
screened out all libraries that had less than 100 UniGenes
associated with it. The final data set that we analyzed con-
sisted of expression information for 96,574 genes across 1573
libraries.
We analyzed gene expression data by using guilt-by-
association (GBA), a combinatoric measure of similarity be-
tween the expression patterns of two genes (Walker et al.
1999). We calculated the pairwise expression similarity be-
tween all 96,574 genes (4.7 billion comparisons).
Cell Culture
Four mammary epithelial cell lines were obtained from ATCC
and examined for mRNA levels. MCF-7 cells were derived
originally from an adenocarcinoma. These cells are estrogen-
receptor positive. HCC1428 cells were first derived from a
metastatic adenocarcinoma. The patient had a family history
of breast cancer. The cells are Her2/neu negative and p53
negative. MCF-10-2F and MCF-10-2A cells are both nontu-
morigenic cell lines (they do not form tumors in immunosup-
pressed mice) that were derived from a 36-year-old female
with fibrocystic breast disease. The MCF-10-2F cells are de-
rived from floating cells, whereas the MCF-10-2A cells are de-
rived from adherent cells.
Mammary epithelial cells were cultured in monolayers in
10-cm2 culture dishes in the recommended medium supple-
mented with chelated or unchelated horse or fetal bovine
serum as applicable, until <80% confluent. Ten dishes of cul-
tured cells, or ∼5–10 107 cells, were solubilized in TRI Re-
agent per the manufacturer’s instructions. RNA extraction,
precipitation, and solubilization were performed as described
by themanufacturer. A total of 0.25mg RNAwas aliquoted for
recovery of poly(A) RNA from each cell line cultured using a
spin-column format (QIAGEN) per the manufacturer’s in-
structions. Poly(A) RNA was quantitated by fluorescence us-
ing the RiboGreen RNA Quantitation Reagent (Molecular
Probes) in 96-well plate format, assayed in triplicate, using the
Fluoroskan Accent FL combination luminometer/fluorometer
(LabSystems). A total of 50 ng mRNA was used for RT–PCR
using the Thermoscript RT–PCR System (GIBCO-BRL/
Invitrogen) to generate cDNA per the manufacturer’s instruc-
tions.
Real-Time PCR
Prior to assaying concentrations of mRNA species from
samples by real-time quantitative PCR, several preparatory
steps were required. First, separate standard curves were gen-
erated for each gene to be analyzed. Genes to be analyzed
were amplified from an appropriate cDNA source (i.e., pros-
tate cDNA from Clontech) by PCR using primers designed
from gene sequences available at www.ncbi.nlm.nih.gov. Am-
plified sequences were gel purified and quantitated by spec-
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troscopy in triplicate. Tenfold serial dilutions of the standard
curve over five orders of magnitude were generated and as-
sayed in duplicate with each sample.
Primers used in the real-time PCR reaction were designed
from sequences internal to those used to amplify the cDNA
for the standard curve, with care taken to encompass all
mRNA variants reported, in case multiple cDNAs were gener-
ated by RT–PCR. In addition, real-time primers were designed
to come from two different exons to eliminate the possibility
of genomic DNA and immature RNA contamination. Results
from real-time PCR are collected as fluorescence over cycle
number. By establishing a fluorescence threshold, a linear
graph is generated of the standard curve using log (concen-
tration) plotted as a function of cycle threshold number. The
equation of the line is then used to determine the starting
concentration of mRNA for each unknown. For each assay,
unknowns are assayed in triplicate with a new standard curve.
Samples are normalized to total mRNA but a housekeeping
gene, GAPD, was also quantitated.
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